Pharmacokinetic drug-drug interactions between olanzapine and valproate need to be better studied.
de Leon
Jose
J
Diaz
Francisco J
FJ
Spina
Edoardo
E
D000927:Anticonvulsants / Q000493:pharmacokinetics* / Q000627:therapeutic use / Q000633:toxicity*; D014150:Antipsychotic Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use / Q000633:toxicity*; D001569:Benzodiazepines / Q000493:pharmacokinetics* / Q000627:therapeutic use / Q000633:toxicity*; D001714:Bipolar Disorder / Q000097:blood* / Q000188:drug therapy*; D002220:Carbamazepine / Q000493:pharmacokinetics / Q000627:therapeutic use / Q000633:toxicity; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D008657:Metabolic Clearance Rate / Q000187:drug effects; D000077152:Olanzapine; D018967:Risperidone / Q000493:pharmacokinetics / Q000627:therapeutic use / Q000633:toxicity; D014635:Valproic Acid / Q000493:pharmacokinetics* / Q000627:therapeutic use / Q000633:toxicity*
D000927:Anticonvulsants; D014150:Antipsychotic Agents; D001569:Benzodiazepines; D002220:Carbamazepine; D014635:Valproic Acid; D018967:Risperidone; D000077152:Olanzapine